These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8158763)

  • 1. Topical minoxidil in the treatment of male erectile dysfunction.
    Radomski SB; Herschorn S; Rangaswamy S
    J Urol; 1994 May; 151(5):1225-6. PubMed ID: 8158763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minoxidil versus nitroglycerin: a prospective double-blind controlled trial in transcutaneous erection facilitation for organic impotence.
    Cavallini G
    J Urol; 1991 Jul; 146(1):50-3. PubMed ID: 1905361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury.
    Chancellor MB; Rivas DA; Panzer DE; Freedman MK; Staas WE
    Urology; 1994 Mar; 43(3):365-9. PubMed ID: 8134992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous minoxidil in the treatment of erectile dysfunctions in spinal cord injured men.
    Beretta G; Saltarelli O; Marzotto M; Zanollo A; Re B
    Acta Eur Fertil; 1993; 24(1):27-30. PubMed ID: 8303971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erectile dysfunction from mechanisms to medicines with a focus on the application of topical Minoxidil.
    Tavakoli MR; Faraji M; Sam S; Ghasempour A; Rezaei M; Langarizadeh MA; Karami-Mohajeri S
    Sex Med Rev; 2023 Apr; 11(2):114-123. PubMed ID: 36857310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minoxidil versus nitroglycerine: a prospective, double-blind, controlled trial in transcutaneous therapy for organic impotence.
    Cavallini G
    Int J Impot Res; 1994 Dec; 6(4):205-12. PubMed ID: 7795721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vacuum constriction device and topical minoxidil for management of impotence.
    Cecchi M; Sepich CA; Felipetto R; Vigano L; Pagni G; Minervini R; Fiorentini L
    Arch Esp Urol; 1995 Dec; 48(10):1058-9. PubMed ID: 8588728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of psychogenic erectile dysfunction in a urological setting: outcomes of 18 consecutive patients.
    Vickers MA; De Nobrega AM; Dluhy RG
    J Urol; 1993 May; 149(5 Pt 2):1258-61. PubMed ID: 8479009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical treatment of erectile dysfunction: randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate.
    Gomaa A; Shalaby M; Osman M; Eissa M; Eizat A; Mahmoud M; Mikhail N
    BMJ; 1996 Jun; 312(7045):1512-5. PubMed ID: 8646143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical therapy in erectile dysfunction].
    Floth A
    Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction.
    Jarow JP; Lowe FC
    J Urol; 1997 Oct; 158(4):1388-90. PubMed ID: 9302127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of duplex ultrasonography and nocturnal penile tumescence in evaluation of impotence.
    Allen RP; Engel RM; Smolev JK; Brendler CB
    J Urol; 1994 Jun; 151(6):1525-9. PubMed ID: 8189562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction.
    Yurkanin JP; Dean R; Wessells H
    J Urol; 2001 Nov; 166(5):1769-72; discussion 1772-3. PubMed ID: 11586221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
    Buvat J; Lemaire A; Marcolin G; Dehaene JL; Buvat-Herbaut M
    J Urol (Paris); 1986; 92(2):111-6. PubMed ID: 2876042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence.
    Ishii N; Watanabe H; Irisawa C; Kikuchi Y; Kubota Y; Kawamura S; Suzuki K; Chiba R; Tokiwa M; Shirai M
    J Urol; 1989 Feb; 141(2):323-5. PubMed ID: 2913354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erectile response to topical, intraurethral and intracorporal pharmacotherapy in a rat model of spinal cord injury.
    Rivas DA; Chancellor MB; Huang B; Salzman SK
    J Spinal Cord Med; 1995 Oct; 18(4):245-50. PubMed ID: 8591071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.